Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1R4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,723
Award facts
- Contract value 100% obligated
- $13,723.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,723.01 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, was issued without set-aside restrictions, demonstrating the contractor's competitive capability in federal pharmaceutical procurement. The contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. Zepbound is a prescription medication approved for weight management, reflecting the DLA's role in supplying critical pharmaceutical products to military and veteran healthcare systems.
This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 31, 2031). That comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The substantial size of the underlying IDC and the frequency of task orders demonstrate Cencora and its subsidiary AmerisourceBergen's established capability to fulfill government contracts for essential pharmaceutical commodities required across the military treatment facility and veterans' healthcare networks.
Quick answers
Who was awarded contract SPE2DR26FA1R4?
SPE2DR26FA1R4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FA1R4 worth?
The government has obligated $13,723 on SPE2DR26FA1R4.
Is contract SPE2DR26FA1R4 an order under another contract?
Yes. SPE2DR26FA1R4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1R4 competed?
The extent of competition for SPE2DR26FA1R4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award